News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Amgen Net Profit Rises, Key Drug Meets Goal
July 27, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
NEW YORK/LOS ANGELES, July 26 (Reuters) - Amgen Inc. on Thursday posted quarterly profit that topped Wall Street expectations, even as sales of its biggest drug, Aranesp, fell 19 percent in the United States amid safety concerns.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Amgen
MORE ON THIS TOPIC
CAR-T
J&J hands lymphoma bispecific CAR T back to AbelZeta
August 17, 2026
·
2 min read
·
Tristan Manalac
Insights
Italian biotech gains momentum as VC funding, tech transfer environment improve
August 17, 2026
·
3 min read
·
Jennifer C. Smith-Parker
Drug Development
Capricor soars on potential FDA review extension, filing amendments
August 14, 2026
·
4 min read
·
Gabrielle Masson
Regulatory
Pressure piles on Amgen after EU pulls Tavneos, flags ‘serious breaches’ in pivotal study
August 14, 2026
·
2 min read
·
Tristan Manalac
